Iranian Red Crescent Medical Journal

Published by: Kowsar

Prokaryotic Expression and Purification of Recombinant Human Leukemia Inhibitory Factor; Analysis of the Ability to Maintain Pluripotency in Embryonic Stem Cells

Behrouz Taheri 1 , Mohammad-Hossein Modarressi 2 , 3 , Mahmoud Hashemitabar 4 , Mohammad Miryounesi 5 and Elahe Motevaseli 2 , 6 , *
Authors Information
1 Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Anatomical Sciences, Cellular and Molecular Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: August 2018, 20 (8); e64813
  • Published Online: September 11, 2018
  • Article Type: Research Article
  • Received: December 5, 2017
  • Revised: March 17, 2018
  • Accepted: April 27, 2018
  • DOI: 10.5812/ircmj.64813

To Cite: Taheri B, Modarressi M, Hashemitabar M, Miryounesi M, Motevaseli E. Prokaryotic Expression and Purification of Recombinant Human Leukemia Inhibitory Factor; Analysis of the Ability to Maintain Pluripotency in Embryonic Stem Cells, Iran Red Crescent Med J. 2018 ; 20(8):e64813. doi: 10.5812/ircmj.64813.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Santos F, Andrade PZ, Abecasis MM, Gimble JM, Chase LG, Campbell AM, et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: A microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods. 2011;17(12):1201-10. doi: 10.1089/ten.tec.2011.0255. [PubMed: 21895491]. [PubMed Central: PMC3226421].
  • 2. Lin J, Liu J, Lu M, Deng S, Ma L. High-level soluble expression, purification, and functional characterization of the recombinant human leukemia inhibitory factor: a potential general strategy for the recombinant expression of cytokines consisting of four alpha-helices in a bundle. Protein Pept Lett. 2011;18(7):690-8. doi: 10.2174/092986611795446058. [PubMed: 21342093].
  • 3. Tomala M, Lavrentieva A, Moretti P, Rinas U, Kasper C, Stahl F, et al. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner. Protein Expr Purif. 2010;73(1):51-7. doi: 10.1016/j.pep.2010.04.002. [PubMed: 20381622].
  • 4. Xi X, Li X, Wu F, Guan X, Jin L, Guo Y, et al. Expression, purification and characterization of active untagged recombinant human leukemia inhibitory factor from E.coli. Protein Expr Purif. 2017;134:139-46. doi: 10.1016/j.pep.2017.03.020. [PubMed: 28347752].
  • 5. Song JA, Koo BK, Chong SH, Kim K, Choi DK, Thi Vu TT, et al. Soluble expression of human leukemia inhibitory factor with protein disulfide isomerase in Escherichia coli and its simple purification. PLoS One. 2013;8(12). e83781. doi: 10.1371/journal.pone.0083781. [PubMed: 24358310]. [PubMed Central: PMC3865251].
  • 6. Aghajanova L. Leukemia inhibitory factor and human embryo implantation. Ann N Y Acad Sci. 2004;1034:176-83. doi: 10.1196/annals.1335.020. [PubMed: 15731310].
  • 7. Cafferty WB, Gardiner NJ, Gavazzi I, Powell J, McMahon SB, Heath JK, et al. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci. 2001;21(18):7161-70. doi: 10.1523/JNEUROSCI.21-18-07161.2001. [PubMed: 11549727].
  • 8. Bauer S, Patterson PH. Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain. J Neurosci. 2006;26(46):12089-99. doi: 10.1523/JNEUROSCI.3047-06.2006. [PubMed: 17108182].
  • 9. Comeron JM, Aguade M. An evaluation of measures of synonymous codon usage bias. J Mol Evol. 1998;47(3):268-74. doi: 10.1007/PL00006384. [PubMed: 9732453].
  • 10. Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, et al. Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells. 2012;30(11):2387-99. doi: 10.1002/stem.1201. [PubMed: 22899336].
  • 11. Rassouli H, Nemati S, Rezaeiani S, Sayadmanesh A, Gharaati MR, Salekdeh GH, et al. Cloning, expression, and functional characterization of in-house prepared human leukemia inhibitory factor. Cell J. 2013;15(2):190-7. [PubMed: 23862122]. [PubMed Central: PMC3712781].
  • 12. Imsoonthornruksa S, Noisa P, Parnpai R, Ketudat-Cairns M. A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli. J Biotechnol. 2011;151(4):295-302. doi: 10.1016/j.jbiotec.2010.12.020. [PubMed: 21219946].
  • 13. Lowe DG, Nunes W, Bombara M, McCabe S, Ranges GE, Henzel W, et al. Genomic cloning and heterologous expression of human differentiation-stimulating factor. DNA. 1989;8(5):351-9. doi: 10.1089/dna.1.1989.8.351. [PubMed: 2475312].
  • 14. Gearing DP, Nicola NA, Metcalf D, Foote S, Willson TA, Gough NM, et al. Production of leukemia inhibitory factor in escherichia coli by a novel procedure and its use in maintaining embryonic stem cells in culture. Nat Biotechnol. 1989;7(11):1157-61. doi: 10.1038/nbt1189-1157.
  • 15. Bessette PH, Aslund F, Beckwith J, Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci U S A. 1999;96(24):13703-8. [PubMed: 10570136]. [PubMed Central: PMC24128].
  • 16. Imaizumi K, Nishikawa S, Tarui H, Akuta T. High-level expression and efficient one-step chromatographic purification of a soluble human leukemia inhibitory factor (LIF) in Escherichia coli. Protein Expr Purif. 2013;90(1):20-6. doi: 10.1016/j.pep.2013.04.006. [PubMed: 23628981].
  • 17. Samal BB, Arakawa T, Boone TC, Jones T, Prestrelski SJ, Narhi LO, et al. High level expression of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia coli and the physical and biological characterization of the protein. Biochim Biophys Acta. 1995;1260(1):27-34. [PubMed: 7999791].
  • 18. Huyton T, Zhang JG, Luo CS, Lou MZ, Hilton DJ, Nicola NA, et al. An unusual cytokine: Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor. Proc Natl Acad Sci U S A. 2007;104(31):12737-42. doi: 10.1073/pnas.0705577104. [PubMed: 17652170]. [PubMed Central: PMC1937536].
  • 19. Fahnert B, Lilie H, Neubauer P. Inclusion bodies: Formation and utilisation. Adv Biochem Eng Biotechnol. 2004;89:93-142. doi: 10.1007/b93995. [PubMed: 15217157].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments